The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B
about
CSN controls NF-kappaB by deubiquitinylation of IkappaBalphaBCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteinsCoupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activationIkappaB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase.Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation.NF-kappa B p100 (Lyt-10) is a component of H2TF1 and can function as an I kappa B-like moleculeRegulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factorsT cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cellsRegulation of the Adaptive Immune Response by the IκB Family Protein Bcl-3NF-κB, the first quarter-century: remarkable progress and outstanding questionsThe ubiquitin-proteasome pathway and proteasome inhibitorsConstitutive NF-kappa B activity in neuronsTax induces nuclear translocation of NF-kappa B through dissociation of cytoplasmic complexes containing p105 or p100 but does not induce degradation of I kappa B alpha/MAD3Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis.Alternative splicing variants of IkappaB beta establish differential NF-kappaB signal responsiveness in human cells.NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer.The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.Cotranslational dimerization of the Rel homology domain of NF-kappaB1 generates p50-p105 heterodimers and is required for effective p50 production.Alternative nuclear functions for NF-κB family membersLPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury.Human cytomegalovirus upregulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters.Persistent activation of NF-kappa B/Rel by human T-cell leukemia virus type 1 tax involves degradation of I kappa B beta.Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteinsMice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitectureA comprehensive map of the toll-like receptor signaling network.A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunitIkappaBalpha deficiency results in a sustained NF-kappaB response and severe widespread dermatitis in mice.The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers.Transformation of avian fibroblasts overexpressing the c-rel proto-oncogene and a variant of c-rel lacking 40 C-terminal amino acids.NF-kappa B p100 is one of the high-molecular-weight proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-kappa BThe roles of the proteasome pathway in signal transduction and neurodegenerative diseases.Old target new approach: an alternate NF-kappaB activation pathway via translation inhibition.The nfkb1 promoter is controlled by proteins of the Ets family.Functional diversity of ankyrin repeats in microbial proteins.Signal-dependent degradation of IkappaBalpha is mediated by an inducible destruction box that can be transferred to NF-kappaB, bcl-3 or p53.Functional interference of Sp1 and NF-kappaB through the same DNA binding site.The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition.Expression of constitutively active IkappaB beta in T cells of transgenic mice: persistent NF-kappaB activity is required for T-cell immune responses
P2860
Q24298155-07C008E3-F876-445A-89AF-F97762220ACEQ24315909-150010A9-526C-48E3-9118-51B851EEFB6EQ24316905-4667E659-5567-47F2-BF1C-AF1A5D0B14A9Q24532221-F690B4D8-D34E-4EE0-9E30-AE64681F8E7EQ24532251-D45C6E0C-30CF-4D66-8DA3-F0D6E9C4209EQ24629772-E5416F91-0293-45AE-9740-F5C87E462FE6Q24651506-8D073B9E-DE99-4359-905E-A0041108F436Q24678251-D0A8420D-27D7-44AC-B099-99F5574004FAQ26749588-50579F38-4589-45FE-8634-AD2EAD2081D7Q26822516-CA83653A-7802-40B7-ABBE-31E232AFBDEBQ28367002-F9C2617E-01BC-4ABF-AFBB-ED1755849EB2Q28582881-901371C3-43C2-4B95-AE5B-C976D4B2BB2BQ28609394-91C8FC8B-88BC-4E5D-97BB-502ADC2CB57BQ30847621-D02EC1FC-94AB-4D2A-97FB-EFB1B6B37295Q33786480-2CF20C90-5D60-4760-AB3A-C59597FD1A26Q34038132-62CE0222-DF95-4E8A-9C41-E4B6A411E5D0Q34061332-879E2791-389C-4452-A08A-4B550934F943Q34489181-D4D727A8-D0CD-4D17-AEB8-D3AAE09243F0Q35263997-FD1B250A-9AA0-4683-A2E1-4D6CEC949025Q35555026-25FC64E1-E7CB-40DD-9C55-EBC93393BB33Q35845633-97FD9756-1C0A-4413-AF05-661F5568F4E9Q35859739-B13A08B7-9024-45A2-9737-47ED6BC359E0Q35864366-3CBE0546-06F4-4869-B963-5FDAEB8D6808Q36400143-1350FCCF-B473-4B5D-8DE3-73F6FB4128B5Q36494115-35A00A74-FB58-4D34-85F0-EED5C5E80CF6Q36559257-A0E259AB-FB5C-4456-A3CF-F4863F2157EBQ36559410-454CFE51-1E13-421F-80C1-79B7DE5D6C69Q36566875-BD63FDBB-154D-41E2-9F82-62293A589374Q36631040-70D9DDE0-4672-4E2C-B408-C818658014CBQ36655517-5E1EF096-10DA-4C95-B77F-0014ECC5EAE1Q36666605-DDC8028A-52F6-421E-8090-DFF3C86B112FQ37171851-A1110948-A09B-4C76-8668-82815250A227Q37338854-4391811C-1985-4B7B-B5B1-0F6154208CA2Q37384802-9B1BE910-0964-4D5C-9A9F-417B4F85996BQ37644958-20D1DD63-8F14-4611-8F31-2C8944706A51Q38337239-9E869E81-F8FA-4A7B-8FF3-0E7F0B5E80F8Q38339684-64CF1002-A637-44F3-887B-14FC672EDB41Q38355384-87682A53-8F30-4747-AFDD-7D0B9F7706F9Q39445143-1D5FB247-FD5E-463A-83F4-3E83A5A1038CQ39631389-DE7DBDCF-503B-4E37-8314-3DB832D4C81A
P2860
The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B
description
1993 nî lūn-bûn
@nan
1993 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
The NF-kappa B precursor p105 ...... ar translocation of NF-kappa B
@ast
The NF-kappa B precursor p105 ...... ar translocation of NF-kappa B
@en
The NF-kappa B precursor p105 ...... ar translocation of NF-kappa B
@nl
type
label
The NF-kappa B precursor p105 ...... ar translocation of NF-kappa B
@ast
The NF-kappa B precursor p105 ...... ar translocation of NF-kappa B
@en
The NF-kappa B precursor p105 ...... ar translocation of NF-kappa B
@nl
prefLabel
The NF-kappa B precursor p105 ...... ar translocation of NF-kappa B
@ast
The NF-kappa B precursor p105 ...... ar translocation of NF-kappa B
@en
The NF-kappa B precursor p105 ...... ar translocation of NF-kappa B
@nl
P2093
P2860
P3181
P1433
P1476
The NF-kappa B precursor p105 ...... ar translocation of NF-kappa B
@en
P2093
C Scheidereit
F G Wulczyn
P2860
P304
P3181
P407
P577
1993-01-01T00:00:00Z